86

DAFTAR PUSTAKA

Akif, M., Masuyer, G., Schwager, S.L.U., Bhuyan, B.J., Mugesh, G., Issac, R.E.,

Sturrock, E.D., & Acharya, K.R., 2011, Structural characterization of

angiotensin I-converting enzyme in complex with a selenium analogue of

captopril, The Febs Journal, 278(19), 3644 - 3650.

Anderson, P.O., Knoben, J.E., and Troutman, W.G., 2002, Handbook of Clinical

Drug Data, 10th edition, , McGraw-Hill Companies, Inc., Sandego, California,

P:326-327.

Anonim, 1982. Captopril: evaluation of low doses, twice-daily doses and the addition

of diuretic for the treatment of mild to moderate hypertension. Veteran

administration cooperative study group on antihypertensive agent.Cooperative

Studies Program of the Veterans Administration Medical Research Service.

Clinical Science 63, 443s-445s.

Anonim, 2008.Angiotensin Converting Enzyme (ACE) Inhibitors.British

Hypertension Society.

Appel LJ et al. 2003.Effects Of Comprehensive Lifestyle Modification On

BloodPressure Control: Main Results Of The Premier Clinical Trial.

JAMA.289:2083-2093.

Armilawaty, Amalia H, dan Amirudin R, 2007, Hipertensi dan Faktor Risikonya

dalam Kajian Epidemiologi. Bagian Epidemiologi FKM UNHAS. Diakses 29

Januari,2014,.

Badia, X., Roca-Cusachs, A., Dalfo, A., Gascon, G., Abellan, J., Lahoz, R., et

al.,2002. Validation of The Short Form of The Spanish Hypertension Quality

of Life Questionnaire (MINICHAL). Clin Ther.24(12): 2137-54.

87

Baharuddin, Kabo, P., Danny, S., 2013.Perbandingan Efektivitas dan Efek Samping

Obat Antihipertensi Terhadap Penurunan Tekanan Darah Pada Pasien

Hipertensi.Bagian Farmakologi, Fakultas Kedokteran, Universitas

Hasanuddin.

Bakris, G.L., 2007, High Blood Pressure. The Merck Manual Home Health

Textbook, Diakses tanggal 29 Juli 2012,

.

Brunner, H.R., Waebber, B., Nussberger, J., 1996, Angiotensin convert- ing enzyme

inhibitors. In: Messerli F, ed. Cardiovascular Drug Therapy, 2nd edn.

Philadelphia: W.B. Saunders: 670-700.

Campbell,B.,C.,Shepherd,A.N.,and Reid,J.,L., 1982.Effects Oftheangiotensinconvertingenzymeinhibitor,captopril,inessential hypertension.Br.J.clin.Pharmac.,13,213-217.

Carvalho, S.A.D., Silva, I.B.S., Ramos, S.B.P., Coelho, L.F., Goncalves, I.D., 2012.

Quality of Life of Hypertensive Patient and Comparasion of Two Instrumen of

HRQOL Measure.Universidade Federal do Maranhao-Sao Luiz, MA-Brazil.

Chapell, M.C., Yamaleyeva, L.M., and Westwood, B.M., 2006, Esterogen and Salt

Sensitivity in the Female mRen(2). Lewis Rat, Diakses Tanggan 10 April

2014,.

Chobanian, A. V., Bakris, G. L.,Black, H. R., Cushman, W. C., Green, L. A., &

Joseph, L. I., 2003. The Seventh Report of the Joint National Committee on

Prevention, Detection, Evaluation, and Treatment of High Blood Preassure,

The U.S Departement of Health and Human Service, Boston.

88

Chobanian, A. V., et al., 2003. The Seventh Report of the Joint National Committee

on Prevention, Detection, Evaluation, and Treatment of High Blood

Preassure.JAMA.289:2560-2572.

Clark, E.M., 2003. Hypertension, in Clinical Pharmacy an Therapeutic. 247-258.

Harcourt Publisher. London.

Cramer, J. A.,& Spilker, B., 1998, Quality of Life and Pharmacoeconomics:dalam

Pharmacotherapy Handbook, 2nd Edition, Appleton and Lange, Stamford,

Connecticut, P: 94-113.

Cushman, D.W., Wang, F.L., Fung, W.C., Grover, G.J., Harvey, C.M, Scalese, R.J.,

Mitch, S.K., & DeForrest, J.M. (1989, April).Comparisons in vitro, ex vivio,

and in vivio of the actions of seven structurally diverse inhibitors of

angiotensin converting enzyme (ACE).British Journal of Clinical

Pharmacology, 28(S2), 115S - 130S.

Ct, I., Grgoire, J.P., Moisan, J., and Chabot,I., 2004., Quality of Life In

Hypertension: The SF-12 Compared To the SF-36, Diakses Tanggal 16 April

2014,.

Depkes, 2006.Pharmaceutical Care Untuk Penyakit Hipertensi.Direktorat Bina

Farmasi Komunitas dan Klinik Ditjen Bina Kefarmasian dan Alat Kesehatan,

Jakarta, Departemen Kesehatan Republik Indonesia.

Depkes, 2013.Formularium Nasional.Diakses pada tanggal 3 April 2014,

.

Dinkes, 2012, Profil Kesehatan Provinsi Jawa Tengah tahun 2012, Yogyakarta,

Departemen Kesehatan Republik Indonesia, Provinsi Yogyakarta.

Dosh, S. A., 2001. The Diagnosis of Essensial and Secondary Hypertension in Adults.

J.Farm Pract:50:707-712.

89

Fahmiruddin, A., 2011. Studi Gejala Efek Samping Captopril Pada Pasien Hipertensi

Rawat Jalan Di Dumah Sakit Daerah dr. Soebandi Jember. Bagian

Komunitas dan Farmasi Klinis Fakultas Farmasi Jember.

Gomer, Beth., 2007, Farmakologi Hipertensi, Terjemahan Diana Lyrawati, 2008.

Penerbit Fakultas Kedokteran Universitas Indonesia. Jakarta.

Gray, H.H., Dawkins, K.D., Morgan, J.M., Sumpson, I.A., 2005. Lecture Notes

Cardiology. Edisi 4.EMS. Jakarta.

Gunawan, L., 2001.,Hipertensi : Tekanan darah tinggi. Yogyakarta: Percetakan Kanisus; 2001.

Hairi, N.N., Hiong, T.G., Bulgiba, A., Mudla, I., 2012, Physical Fungtion in Older

People, Geriatrics, Prof. Craig Atwood (Ed.), ISBN: 978-953-51-0080-5, In

tech. diakses tanggal 20 Juni 2014,

.

He, J., 2000. Long-Term Effects Of Weight Loss And Dietary Sodium Reduction On

Incidence Of Hypertension. Hypertension;35:544-549.

Hu, Yu, and ZHU Junren, 1999.Quality of Life of Patients with Mild Hypertension

Treated With Captopril: a Randomized Double-Blind Placebo-Controlled

Trial. Chinese Medical Journal;112(4):302-307.

Ikawati, Z., Jumiani,S. dan Putu,I.D.P.S., 2008. Kajian Keamanan Pemakaian Obat

Antihipertensi di Poliklinik Usia Lanjut RS DR. Sardjito.Yogyakarta.Jurnal

Farmasi Indonesia Vol. 4 No. 1:30-41.

Israili, Z.H., Hall, W.D., 1992, Cough and angioneurotic edema associated with ACE

inhibitor therapy a review of the literature and pathophysiology. Ann

Intern Med;117: 234-42.

90

Jimbo, Masahito.,MD., 2009. Essential Hypertension, UMHS Hypertension

Guaideline, Guidelines for Clinical Care Ambulatory, Univesity of Michigan

Kabo, P., 2011. Bagaimana Menggunakan Obat-Obat Kardiovaskuler Secara

Rasional. Penerbit Fakultas Kedokteran Universitas Indonesia.

Kemenkes. 2013. Riset Kesehatan Dasar (RISKERDAS), Jakarta,Badan Penelitian

dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia.

Lacourciere, Y., Brunner, H.R., Irwin, R., Karlberg, B.E., Ramsay, L.E., 1994,

Effects of modulators of the renin-angiotensin aldoster- one system on cough.

J Hypertension;12: 1387-93.

Lees, K.R., Kelman, A.W., Reid, J.L., Whiting, B., 1989, Pharmacokinetic of an ACE

inhibitor S9780 in man: Evidence of tissue binding, J Pharmacokinet

Biopharm; 17: 529-50.

Lima, M.G., Barros, M.B.A., Cesar, C.L.G., Goldbaum, M., Carandina, L., Ciconelli,

R.M.,2009, Health related quality of life among the elderly: a population-base

study using SF-36 survey, Cad. Saude Publica, Rio de Jenero, 25(10):2159-

2167.

Luigi, C.M.D., Maurizio, B.M.D., Paolo, V.M.D., Low dose Captopril Therapy in

Mild and Moderate Hypertension. Radomized Comparison of Twice day vs

three Times Daily Doses.Hypertension.5:III157. Hypertension is Published

by the American Heart Assosiation, Greenville Avenue, Dallas.

Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E., 1997. Thromboxane

antagonism and cough induced by angiotensin-converting enzyme inhibitor.

Lancet; 350: 1517.

Manolis, S. Kallistratos., 2010.Diagnostic Modalities of the Most Common Form of

Secondary Hypertension.Cardiology Department and Cardiovascular

91

Protection Clinic, Asklepeion Hospital, Athens, Greece. Hellenic J Cardiol;

51: 518-529.

Mansjoer, A., dkk, 2001.Kapita Selekta Kedokteran Jilid I :Nefrologi danHipertensi.Jakarta: Media Aesculapius FKUI; 2001. p: 519-520.

Murphy, B. et al., 2000. Australian WHOQL-100, WHOQL-BREF and CA-WHOQL

INSTRUMENT; user manual and interpretation guide. Diakses pada14 Maret

2014, .

Natesh, R., Schwager, S.L.U., Evans, H.R., Sturrock, E.D., & Acharya, K.R., 2004,

Structural details on the binding of antihypertensive drugs captropril and

enalaprilat to human testicular angiotensin I-converting enzyme,

Biochemistry, 43, 8718 - 8724.

Oparil, S., et al., 2003.Pathogenesis of Hypertension. Ann Intern Med;139:761-776.

Paul, M., Mehr, A.P, & Kreutz, R., 2006, Physiology of Local Renin- Angiotensin

Systems, Physiological Reviews, 86(3), 747 803.

Prasetio,S.D, dan Chrisandyani,D., 2009. Gambaran Efek Samping Obat

Antihipertensi pada Pasien Hipertensi di Instalasi Rawat Inap RS PKU

Muhammadiyah Yogyakarta.diakses oktober 2013,

.

Rahajeng, E., Tuminah, S., 2009.Prevalensi Hipertensi Dan Determinannya Di

Indonesia. Majalah Kedokteran Indonesia, Vol: 59, No: 12, Desember 2009.

Richer, C., Giroux, B.,Plouin, P., F.,Maarek, B., and Giudicelli, J.F. 1984.Captopril: pharmacokinetics, antihypertensive and biological effects in hypertensive patients. Br J Clin Pharmacol. Mar 1984; 17(3): 243250.

92

Ryan, J.W., Chung, A., Berryer, P., Murray, M.A., Ryan, J.P.A., 1986, Slow tight

binding inhibitors of angiotensin converting enzyme, Adv Exp Med Biol, 198:

419-25

Sassen, J.J., MacLaughlin, E.J., in Hypertension, Dipiro, J.T., Talbert, R.L., Yee,

G.C., Matzke, G.R., Wells, B.G., Posey, L.M., (Eds), 2008. Pharmacotherapy

A Pathiphysiologic Approach, seventh Edition, 139-172, McGraw Hill,

Medical Publishing Division, New York.

Schulz, R.B., Rossignoli, P., Corrner, C.J., Fernandes, L. F., Toni, P.M.,

2007.,Validation of The Short Form of The Spanish Hypertension Quality of

Life Questionnaire (MINICHAL) for Portuguese (Brazil). Universidade

Federal do Parana, Universidade Tuluti do Parana, Centro Universitario

Positivo, Universidade de Lisboa, Curitiba, PR- Brazil, Lisbon, Portugal, Arq

Bras Cardiol. 2008;90(2):127-131.

Spilker, B., 1996, Quality of Life and Pharmacoeconomics in Clinical Trial, 2nd

edition, 192-195, 517-8898 Lippincott-Raven Publisher, Philadelphia.

Susilo, Y., Wulandari, A., 2011. Cara Jitu Mengatasi Hipertensi, C.V Andi Offset,

Yogyakarta.

Swedberg, K., Held, P., Kjekshus, J., Rasmussen, P., Ryden, L., Weach, H., 1992,

Effects of early administration of enalapril in patients with acute myocardial

infarction' Results of the Cooperative New Scandinavian Enalapril Survival

Study II. N Engl J Med; 327: 678-84.

Testa, M. A., & Simonson, D. C., 1996, Assesment of Quality of Life Outcomes,

diaksespada08April2014,

.

93

Vane, J.R., 1967, Conversion of Angiotensin I to Angiotensin II, Nature, 216, 762 -

766.

Weibert, R.T., dalam Herfindal, E.T., dan Gourley, D.R., 2000, Textbook of

Therapeutics: Drug and Disease Management, 7th edition, 795-820, Lippincot

Williams and Wilkins, USA.

Whelton P. K., 1998.Sosium Reduction And Weight Loss In The Treatment

OfHypertension In Older Persons: A Randomized, Controlled Trial Of

Nonpharmacologic Interventions In The Elderly.JAMA. 279:839-846.

WHO, 2011.Data Global Status Report on Communicable Diseases 2010.

Yogiantoro M., 2006. Hipertensi Esensial. Dalam Buku Ajar Ilmu Penyakit Dalam

Jilid I Edisi ke IV. Pusat Penerbitan Departemen Ilmu Penyakit Dalam.

Fakultas Kedokteran Universitas Indonesia. Jakarta: 610-14.